Philip Janiak

Philip Janiak has worked as the Principal CEO at Corteria Pharmaceuticals since August 2021. Prior to that, they held the role of Research Head in the Cardiovascular Disease and Fibrosis Unit at Sanofi from an unspecified start date until December 2021.

Philip Janiak completed their education at two institutions. Philip began their education at the Faculty of Pharmacy in Paris from 1979 to 1984, earning a PharmD degree. Later, from 1985 to 1989, they pursued a PhD in Cardiovascular Pharmacology at the University of Iowa Roy J. and Lucille A. Carver College of Medicine.